The article will briefly explain the processes of organized screening in the NHS Cervical Screening Programme (NHSCP). Quality control is well established and monitored by regional quality assurance reference centres. The final outcome of screening is also monitored by national cervical cancer mortality and incidence rates: data will be presented for rates of in situ and invasive cervical carcinoma before and after the introduction of organized screening. The NHSCSP is using the introduction of liquid-based cytology as a platform for modernization, which is planned to include high-risk human papillomavirus (HR HPV) testing for low-grade cytology triage as well as a test of cure after treatment. Trials of computer-assisted screening are also in progress. High standards of quality control will be needed in the era of vaccination, when prevalence of preinvasive and invasive cervical cancer will decline. The NHSCSP is well placed to take on these challenges, if necessary by introducing primary HR HPV testing so that cytology screening can be concentrated on women who are genuinely at risk.
- MeSH
- cytologické techniky metody trendy využití MeSH
- epidemiologie MeSH
- lidé MeSH
- nádory děložního čípku diagnóza MeSH
- plošný screening metody normy využití MeSH
- senzitivita a specificita MeSH
- statistika jako téma MeSH
- vládní programy metody organizace a řízení statistika a číselné údaje MeSH
- výsledky a postupy - zhodnocení (zdravotní péče) MeSH
- Check Tag
- lidé MeSH
- Geografické názvy
- Anglie MeSH
National and international experts in cervical cancer prevention met at the International Workshop on Human Papillomaviruses and Consensus Recommendations for Cervical Cancer Prevention to review the current evidence and assess the potential for improvement in cervical cancer prevention and to develop plans for implementation of cervical cancer prevention programmes in Croatia. Key recommendations were developed and adopted during the course of the meeting. The process of bringing national experts together with internationally recognized experts in an open forum for the development of consensus recommendations could serve as a model for other countries seeking to implement or improve cervical cancer prevention programmes.
- MeSH
- dysplazie děložního hrdla diagnóza prevence a kontrola diagnóza prevence a kontrola MeSH
- Evropská unie MeSH
- nádory děložního čípku diagnóza prevence a kontrola MeSH
- plošný screening metody organizace a řízení využití MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- vakcíny proti papilomavirům aplikace a dávkování terapeutické užití MeSH
- Geografické názvy
- Chorvatsko MeSH
Cytopathology, ISSN 1350-4037 ; Supplement Vol. 6. 2
32 s. : tab. ; 24 cm